SkyCell is a leading airfreight container provider with the mission to supply the safest pharma containers worldwide.
SkyCell designs and manufactures smart containers that allow pharmaceutical companies to predict, reduce, and control the risks associated with transporting temperature-sensitive drugs.
SkyCell was founded in 2013 by Richard Ettl and Nico Ros. The company is headquartered in Zurich, Zurich, Switzerland.
SkyCell has developed a shipping container that maintains temperature, controls vibration and is outfitted with sensors that continuously report the status of the cargo. The idea is to minimize temperature excursions, harmful fluctuations that can spoil drug products, and other damage that happens during shipping.
SkyCell can offer containers meeting every temperature requirement. SkyCell has also launched a SaaS solution, SECURE, that provides pharma companies with end-to-end oversight of every shipment around the world and an automated approval capability that reduces quality approval time to just minutes.
SkyCell works with the majority of the top 20 pharmaceutical companies. Existing partners include Qatar, Saudia Cargo, KLM Airfrance Martinair Cargo, Korean Air, LOT, Virgin Atlantic, JAL, All Nippon Airways, DB Schenker, DSV, and others.
SkyCell is backed by Swiss Entrepreneurs Fund, MVM Partners LLP, UBS, DisruptAD, SHUAA, BCGE Bank, and others. The company raised $35M in Series C round on Oct 11, 2021. This brings SkyCell's total funding to $133M to date.